Ward AB, Wilson IA (2017) The HIV-1 envelope glycoprotein structure: nailing down a moving target. Immunol Rev 275:21–32. https://doi.org/10.1111/imr.12507
Article CAS PubMed PubMed Central Google Scholar
Bomsel M, Tudor D, Drillet AS et al (2011) Immunization with HIV-1 Gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34:269–280. https://doi.org/10.1016/j.immuni.2011.01.015
Article CAS PubMed Google Scholar
Leggat DJ, Cohen KW, Willis JR et al (2022) Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science 378(6623):eadd6502. https://doi.org/10.1126/science.add6502
Article CAS PubMed PubMed Central Google Scholar
Horvath A, Rogers L, Pollakis G et al (2023) Systematic comparison of HIV-1 envelope-specific IgG responses induced by different vaccination regimens: can we steer IgG recognition towards regions of viral vulnerability? Front Immunol 13:1075606. https://doi.org/10.3389/fimmu.2022.1075606
Article CAS PubMed PubMed Central Google Scholar
Chapman R, van Diepen M, Galant S et al (2020) Immunogenicity of HIV-1 vaccines expressing chimeric envelope glycoproteins on the surface of Pr55 Gag virus-like particles. Vaccines (Basel) 8(1):54. https://doi.org/10.3390/vaccines8010054
Article CAS PubMed PubMed Central Google Scholar
Yi HA, Fochtman BC, Rizzo RC, Jacobs A (2016) Inhibition of HIV entry by targeting the envelope transmembrane subunit Gp41. Curr HIV Res 14:283–294. https://doi.org/10.2174/1570162x14999160224103908
Article CAS PubMed PubMed Central Google Scholar
Zhuang M, Vassell R, Yuan C et al (2019) Mutations that increase the stability of the postfusion Gp41 conformation of the HIV-1 envelope glycoprotein are selected by both an X4 and R5 HIV-1 virus to escape fusion inhibitors corresponding to heptad repeat 1 of Gp41, but the Gp120 adaptive mutations differ between the two viruses. J Virol 93:e00142-19. https://doi.org/10.1128/jvi.00142-19
Article CAS PubMed PubMed Central Google Scholar
Hikichi Y, Van Duyne R, Pham P et al (2021) Mechanistic analysis of the broad antiretroviral resistance conferred by HIV-1 envelope glycoprotein mutations. MBio 12(1):e03134-20. https://doi.org/10.1128/mbio.03134-20
Article CAS PubMed PubMed Central Google Scholar
Dimonte S, Babakir-Mina M, Aquaro S, Perno CF (2013) Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals. Infection 41:1097–1102. https://doi.org/10.1007/s15010-013-0464-5
Article CAS PubMed Google Scholar
Dimonte S (2017) Different HIV-1 env frames: Gp120 and ASP (antisense protein) biosynthesis, and theirs co-variation tropic amino acid signatures in X4- and R5-viruses. J Med Virol 89:112–122. https://doi.org/10.1002/jmv.24611
Article CAS PubMed Google Scholar
Hightower GK, May SJ, Pérez-Santiago J et al (2013) HIV-1 clade B pol evolution following primary infection. PLoS ONE 8:e68188. https://doi.org/10.1371/journal.pone.0068188
Article CAS PubMed PubMed Central Google Scholar
Tajima F, Nei M (1984) Estimation of evolutionary distance between nucleotide sequences. Mol Biol Evol 1:269–285. https://doi.org/10.1093/oxfordjournals.molbev.a040317
Article CAS PubMed Google Scholar
Nei M, Gojobori T (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3:418–426. https://doi.org/10.1093/oxfordjournals.molbev.a040410
Article CAS PubMed Google Scholar
Kumar S, Stecher G, Tamura K (2016) MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 33:1870–1874. https://doi.org/10.1093/molbev/msw054
Article CAS PubMed PubMed Central Google Scholar
Yang OO (2009) Candidate vaccine sequences to represent intra- and inter-clade HIV-1 variation. PLoS ONE 4:e7388. https://doi.org/10.1371/journal.pone.0007388
Article CAS PubMed PubMed Central Google Scholar
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Ser A Gen 57:289–300
Kryazhimskiy S, Plotkin JB (2008) The population genetics of dN/dS. PLoS Genet 4:e1000304. https://doi.org/10.1371/journal.pgen.1000304
Article CAS PubMed PubMed Central Google Scholar
Dimonte S, Mercurio F, Svicher V et al (2011) Selected amino acid mutations in HIV-1 B subtype Gp41 are associated with specific Gp120V3 signatures in the regulation of co-receptor usage. Retrovirology 8:33. https://doi.org/10.1186/1742-4690-8-33
Article CAS PubMed PubMed Central Google Scholar
van Gils MJ, van den Kerkhof TL, Ozorowski G et al (2016) An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability. Nat Microbiol 2:16199. https://doi.org/10.1038/nmicrobiol.2016.199
Article CAS PubMed PubMed Central Google Scholar
Montero M, van Houten NE, Wang X, Scott JK (2008) The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev 72:54–84. https://doi.org/10.1128/mmbr.00020-07
Article CAS PubMed PubMed Central Google Scholar
Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, Parks RJ, Hicks CB, Owzar K, Tomaras GD, Montefiori DC, Haynes BF, Delfraissy JF (2009) Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 23:897–906. https://doi.org/10.1097/qad.0b013e328329f97d
Article CAS PubMed PubMed Central Google Scholar
Walker LM et al (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326:285–289. https://doi.org/10.1126/science.1178746
Article CAS PubMed PubMed Central Google Scholar
Zhang X, Zhang F, Ma X et al (2016) Identification of interaction between HIV-1 glycoprotein 41 and integrase. Virol Sin 31:415–424. https://doi.org/10.1007/s12250-016-3820-7
Article CAS PubMed PubMed Central Google Scholar
Qualls ZM, Choudhary A, Honnen W et al (2018) Identification of novel structural determinants in MW965 Env that regulate the neutralization phenotype and conformational masking potential of primary HIV-1 isolates. J Virol 92:e01779-17. https://doi.org/10.1128/jvi.01779-17
Article CAS PubMed PubMed Central Google Scholar
Postler TS, Desrosiers RC (2013) The tale of the long tail: the cytoplasmic domain of HIV-1 Gp41. J Virol 87:2–15. https://doi.org/10.1128/jvi.02053-12
Article CAS PubMed Google Scholar
Santos da Silva E, Mulinge M, Perez BD (2013) The frantic play of the concealed HIV envelope cytoplasmic tail. Retrovirology 10:54. https://doi.org/10.1186/1742-4690-10-54
Comments (0)